Medical Device Adhesive Market Size and Share
Medical Device Adhesive Market Analysis by Mordor Intelligence
The Medical Device Adhesive Market size is estimated at USD 11.12 billion in 2025, and is expected to reach USD 15.93 billion by 2030, at a CAGR of 7.45% during the forecast period (2025-2030). Strong demand for skin-friendly bonding agents in wearable monitors, minimally invasive catheters, and home-infusion systems is widening end-use breadth. Investments in UV-curable chemistries are shortening assembly cycles, while hydrogel and bio-resorbable options reduce medical adhesive–related skin injuries. Supply-chain recalibration, prompted by silicone feedstock swings, is spurring dual-sourcing strategies among device OEMs. Regulatory tightening around EU-MDR traceability is pushing manufacturers toward specialized formulators that can supply compliant, lot-level track-and-trace solutions.
Key Report Takeaways
- By resin, acrylics led with 29.89% of medical device adhesive market share in 2024, while silicones are projected to expand at a 7.89% CAGR through 2030.
- By technology, water-based systems held 35.43% of the medical device adhesive market size in 2024; UV-curable systems record the highest forecast CAGR at 7.90% to 2030.
- By adhesive form, pressure-sensitive films accounted for 37.78% of the medical device adhesive market size in 2024; gels and hydrocolloid patches are advancing at a 7.85% CAGR.
- By application, medical devices and equipment captured 44.56% of medical device adhesive market share in 2024; internal medical uses are growing at an 8.10% CAGR.
- By geography, North America remained the largest regional contributor with 38.78% revenue share in 2024; Asia–Pacific is anticipated to post the fastest CAGR through 2030.
Global Medical Device Adhesive Market Trends and Insights
Driver Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Surge in remote-monitoring and wearable therapeutic devices | +1.8% | Global, with concentration in North America & EU | Medium term (2-4 years) |
| Expansion of single-use and minimally-invasive catheter platforms | +1.5% | Global, strongest in developed markets | Short term (≤ 2 years) |
| Growth in home-infusion pumps requiring long-wear PSAs | +1.2% | North America & EU, expanding to APAC | Medium term (2-4 years) |
| Wider adoption of hydrogel and bio-resorbable adhesive chemistries | +0.9% | Global, led by research centers in US, EU, Asia | Long term (≥ 4 years) |
| OEM outsourcing driven by EU-MDR traceability mandates | +0.8% | EU primary, spillover to global supply chains | Short term (≤ 2 years) |
| Source: Mordor Intelligence | |||
Surge in Remote-Monitoring and Wearable Therapeutic Devices
Seven-day to 30-day wear intervals for glucose monitors, cardiac patches, and drug-delivery wearables require low-trauma adhesion and moisture-vapor permeability. Advanced silicone-acrylic hybrids maintain tack after exposure to perspiration and gamma sterilization, limiting property loss associated with cross-link density shifts[1]Avery Dennison Medical, “Solving Extended-Wear Challenges in Connected Health,” averydennison.com. Polyelectrolyte-complex additives pioneered at Texas A&M attenuate skin irritation by lowering residual monomer content[2]Guangyu Li et al., “Low-Trauma Silicones for Medical Tapes,” TAMU.edu. Suppliers such as Panacol have commercialized post-cure moisture-activated formulations that strengthen in-use, extending service life for connected health patches. The next frontier involves smart adhesives embedded with micro-sensors that trigger app-based replacement alerts, improving patient compliance.
Expansion of Single-Use and Minimally Invasive Catheter Platforms
Catheter makers are migrating toward LED-activated UV acrylates that reach handling strength in 10–30 seconds, trimming takt times and floor-space needs. Automated jet-dispense heads from Nordson meter sub-micron beads that minimize squeeze-out and reduce material scrap. Thermoplastic polyurethane-to-metal bonding hurdles are being addressed through low-modulus cyanoacrylate tie-layers developed by Master Bond that mitigate galvanic corrosion. Electroceutical catheters employing voltage-triggered sealants have entered first-in-human trials, bridging the gap between passive and active closure systems. These innovations blur traditional device-pharma demarcations, compelling regulators to craft hybrid approval pathways.
Growth in Home-Infusion Pumps Requiring Long-Wear PSAs
Long-wear devices in home settings require balanced peel strength and gentle removal. Low-trauma silicones from Boyd Biomedical show 80% retention of adhesion after 14 days yet detach without epidermal stripping. Breathable acrylic PSAs with controlled moisture-vapor transmission avert maceration during extended use. Research into self-reinforcing hydrogel matrices demonstrates in-situ cross-link growth, delivering a 30-day target wear time without mid-cycle dressing change. Raw-material volatility, especially in medical-grade silicone, is pushing OEMs to pre-qualify secondary suppliers to buffer cost spikes.
Wider Adoption of Hydrogel and Bio-Resorbable Adhesive Chemistries
Hydrogels exploiting hydrogen bonding and van der Waals forces offer atraumatic adhesion to moist tissue while degrading into benign by-products. Chitosan-dextran blends under development at Taipei Medical University achieve surgical-grade sealing within 60 seconds and fully resorb inside eight weeks. 3D-printed hydrogel patches molded to patient-specific anatomies have shown promising hemostasis results in porcine trials. Scale-up requires inline water-activity monitoring and aseptic package fills distinct from film-coat production lines. Early adoption is expected in high-value surgical sealant niches before broader diffusion to routine dressings.
Restraint Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Complex ISO-10993 biocompatibility and extractables testing burden | -1.3% | Global, most stringent in EU and US | Short term (≤ 2 years) |
| Cost volatility of medical-grade silicone and specialty acrylates | -0.8% | Global, supply chain concentrated in China | Medium term (2-4 years) |
| Sterilization‐induced property degradation (e-beam, EtO) | -0.6% | Global, critical in regulated markets | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Complex ISO-10993 Biocompatibility and Extractables Testing Burden
Full ISO-10993 panels for a single formulation can cost up to USD 200,000 and stretch commercialization by 18 months. Extractables thresholds tighten annually as chromatography sensitivity improves, demanding iterative toxicological risk assessments. SMEs lacking in-house toxicologists often outsource, raising overhead and tilting competitive advantage toward integrated multinationals. Divergent U.S. FDA and EU-MDR documentation formats force parallel dossiers, adding redundancy and pushing some start-ups to launch region-specific SKUs first.
Cost Volatility of Medical-Grade Silicone and Specialty Acrylates
Silicone feedstock shortages linked to metallurgical-grade silicon curbs in China lifted medical-grade prices by 30-50% during 2024. Adhesive producers carrying lean inventories faced margin compression or rushed re-formulation. Specialty acrylates derived from acrylic acid witnessed similar swings following propylene price spikes, creating hedging challenges. Alternatives such as moisture-cure silyl-terminated polyethers are under evaluation, but limited ISO-10993 lineage slows substitution.
Segment Analysis
By Resin: Acrylic Dominance Faces Silicone Innovation
Acrylics captured 29.89% of medical device adhesive market size in 2024, underpinning wound-care tapes and diagnostic strips that benefit from high initial tack and temperature resilience. Revenue momentum persists in ostomy pouches and surgical drapes where long-dwell stability offsets moderate cost per square meter. Silicones, advancing at a 7.89% CAGR, gain traction in pediatric, geriatric, and oncology segments where epidermal integrity is crucial. Their low surface energy allows atraumatic removal without residue, a priority as value-based healthcare penalizes medical adhesive–related skin injury claims.
Manufacturing economics are tilting as automated meter-mix equipment scales silicone throughput and narrows historical cost gaps with acrylics. Next-generation soft-skin silicone sheets introduced by DuPont achieve controlled modulus gradients, balancing secure adhesion with painless removal. Acrylic suppliers respond by grafting silicone segments onto acrylic backbones, forming hybrid systems that approach silicone gentleness while retaining acrylic economics. Cyanoacrylate tissue sealants remain indispensable for rapid wound closure, supported by H.B. Fuller’s Medifill acquisition that strengthened its surgical adhesive franchise.
Note: Segment shares of all individual segments available upon report purchase
By Technology: Water-Based Leadership Challenged by UV Innovation
Water-based dispersions held 35.43% medical device adhesive market share in 2024, benefiting from low-VOC regulations and existing coat-dry assets. Their dominance, however, faces headwinds from UV-curable acrylates which are registering a robust 7.90% CAGR. UV systems leverage on-demand curing to shrink work-in-progress inventories and enable rapid lamination of heat-sensitive substrates central to next-gen diagnostics. LED UV lamps cut power consumption by 50% versus mercury arc units, meeting hospital sustainability goals.
Hot-melts persist in high-speed surgical drape lines where instantaneous set facilitates roll-to-roll throughput. Nonetheless, process engineers increasingly weigh the ergonomic benefits of UV against capex amortization of water-based coaters. Solvent-borne chemistries continue a secular decline under stricter plant-emission caps instituted across the EU and California, pushing formulators to rationalize legacy SKUs.
By Adhesive Form: Pressure-Sensitive Films Drive Market Growth
Pressure-sensitive films accounted for 37.78% of medical device adhesive market size in 2024. Multi-layer constructions combine high tack surfaces with breathable backings, enabling secure yet comfortable fixation of infusion lines and bio-sensors. The category’s scalability aligns with roll-convert manufacturing, keeping unit costs competitive. Gels and hydrocolloid patches are the fastest risers at 7.85% CAGR, propelled by chronic wound clinics that favor moisture-retentive dressings. Research at Aalto University demonstrated self-healing hydrocolloids that recover up to 90% tensile strength within four hours, cutting dressing change frequency.
Structural liquids fill precision bonding niches such as pacemaker header encapsulation where low-shrinkage epoxies prevent micro-crack propagation. Spray and foam formats accommodate irregular geometries in orthopedic casting and prosthetic liner bonding, albeit with lower total addressable volume.
By Application: Medical Devices Lead While Internal Uses Surge
Medical devices and equipment retained 44.56% of medical device adhesive market share in 2024, spanning monitor housings, catheter assemblies, and imaging probes. Investment in next-gen ventilators and point-of-care ultrasounds sustains baseline demand. Internal medical uses, advancing at an 8.10% CAGR, reflect the shift from sutures to tissue sealants in minimally invasive surgery. Injectable hydrogel plugs reported in Science Advances achieved hemostasis within 60 seconds in cardiac models, underscoring potential to reduce OR time.
Dental indications enjoy stable replacement cycles driven by aesthetic restoratives and orthodontic brackets that rely on moisture-tolerant resin-modified glass ionomers. Other applications include veterinary wearables tracking equine heart rate, leveraging skin-sealed sensors for race-day analytics.
Note: Segment shares of all individual segments available upon report purchase
Geography Analysis
North America’s medical device adhesive market size benefits from entrenched OEM–materials partnerships, robust post-market surveillance, and accelerated review channels for breakthrough devices. Skin-friendly silicone tape adoption in ambulatory infusion centers has doubled since 2023, reflecting payer incentives for home-based care. Federal subsidies for semiconductor packaging have ancillary spillovers into medical electronics and adhesive demand.
Europe’s regulatory rigor reinforces demand for fully documented, traceability-enabled formulations. EU-MDR unique device identifier (UDI) requirements spurred lot-level serialization of adhesive rolls, integrating barcode serialization at the coater stage. Sustainability directives add momentum to water-based systems as plants gear toward carbon-footprint audits.
Asia–Pacific is witnessing capital flows into UV-curable line installs, leveraging regional LED supply chains. Domestic players in China and South Korea now export class II wearables, necessitating ISO-10993-compliant adhesive imports or local toll-manufacturing. ASEAN initiatives for mutual recognition of device approvals lower entry hurdles, broadening addressable volume for multinational and regional suppliers alike.
Competitive Landscape
The medical device adhesive market exhibits moderately fragmented. 3M retains leadership through vertically integrated acrylic and silicone portfolios and global converting assets. Henkel leverages Loctite’s structural expertise and broad UV-curable range, steering co-development programs with catheter OEMs. Avery Dennison capitalizes on hydrogel competence and tailors skin-contact tapes for digital-therapeutic brands.
Challengers include DuPont, scaling soft-skin silicones with differentiated modulus gradients, and Panacol, advancing post-cure moisture systems for long-wear patches. H.B. Fuller’s recent acquisition of Medifill deepens cyanoacrylate offerings in surgical sealants. Forgeway and Master Bond serve niche bond-line engineering needs, particularly for implantables requiring ultra-low extractables.
Intellectual-property filings cluster around bio-resorbable constructs inspired by mussel byssus proteins, signaling future disruption in wet-tissue adhesion. Competitive edge is shifting from raw bond strength to regulatory fluency, supply-chain resilience, and sustainability credentials as ESG audits become table stakes for hospital procurement.
Medical Device Adhesive Industry Leaders
-
3M
-
Arkema
-
Dow
-
H.B. Fuller Company
-
Henkel AG & Co. KGaA
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- January 2025: Henkel introduces advanced light cure adhesives designed for the assembly of flexible medical devices. The company launches two innovative adhesives: Loctite AA 3952 and Loctite SI 5057. These adhesives are specifically formulated to bond TPE substrates, effectively addressing the limitations of traditional assembly methods.
- December 2024: H.B. Fuller strengthens its medical adhesives business through the acquisition of GEM & Medifill. The company has entered into agreements to acquire these two medical adhesive technology firms, enhancing its position in the medical adhesive market.
Global Medical Device Adhesive Market Report Scope
| Acrylic |
| Cyanoacrylate |
| Silicone |
| Polyurethane |
| Epoxy |
| Other Resins |
| Water-based |
| Solvent-based |
| Hot-melt |
| UV or Radiation-curable |
| Pressure-Sensitive Films and Tapes |
| Structural / Semi-Structural Liquids |
| Gels and Hydrocolloid Patches |
| Sprayable / Foam Adhesives |
| Medical Devices and Equipment |
| External Medical Application |
| Dental |
| Internal Medical Applications |
| Others |
| Asia-Pacific | China |
| India | |
| Japan | |
| South Korea | |
| Australia and New Zealand | |
| Rest of Asia-Pacific | |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Russia | |
| NORDIC Countries | |
| Rest of Europe | |
| South America | Brazil |
| Argentina | |
| Rest of South America | |
| Middle East and Africa | Saudi Arabia |
| Turkey | |
| Israel | |
| South Africa | |
| Egypt | |
| Rest of Middle East and Africa |
| By Resin | Acrylic | |
| Cyanoacrylate | ||
| Silicone | ||
| Polyurethane | ||
| Epoxy | ||
| Other Resins | ||
| By Technology | Water-based | |
| Solvent-based | ||
| Hot-melt | ||
| UV or Radiation-curable | ||
| By Adhesive Form | Pressure-Sensitive Films and Tapes | |
| Structural / Semi-Structural Liquids | ||
| Gels and Hydrocolloid Patches | ||
| Sprayable / Foam Adhesives | ||
| By Application | Medical Devices and Equipment | |
| External Medical Application | ||
| Dental | ||
| Internal Medical Applications | ||
| Others | ||
| By Geography | Asia-Pacific | China |
| India | ||
| Japan | ||
| South Korea | ||
| Australia and New Zealand | ||
| Rest of Asia-Pacific | ||
| North America | United States | |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Russia | ||
| NORDIC Countries | ||
| Rest of Europe | ||
| South America | Brazil | |
| Argentina | ||
| Rest of South America | ||
| Middle East and Africa | Saudi Arabia | |
| Turkey | ||
| Israel | ||
| South Africa | ||
| Egypt | ||
| Rest of Middle East and Africa | ||
Key Questions Answered in the Report
How large is the medical device adhesive market in 2025?
The medical device adhesive market size is USD 11.12 billion in 2025.
What is the expected CAGR for medical device adhesives through 2030?
Aggregate revenue is forecast to expand at a 7.45% CAGR between 2025 and 2030.
Which resin type is growing fastest within medical adhesives?
Silicones show the quickest growth, advancing at a 7.89% CAGR due to demand for skin-friendly wearables.
Why are UV-curable systems gaining share?
They cure in seconds under LED lamps, boosting throughput and lowering solvent emissions, driving a 7.90% CAGR in the segment.
Page last updated on: